CCL3 and neoplasm: In models of lung cancer, genetic knockout of progranulin (PGRN)-a protein known to suppress immune responses and promote tumor progression- resulted in robust upregulation of CCL3 in CD8+ T cells, correlating with enhanced infiltration, proliferation, and effector function.